Reuters logo
BRIEF-Boehringer Ingelheim, Gubra collaborate to develop obesity treatments
September 7, 2017 / 12:20 PM / 2 months ago

BRIEF-Boehringer Ingelheim, Gubra collaborate to develop obesity treatments

Sept 7 (Reuters) - Boehringer Ingelheim

* Boehringer Ingelheim and Gubra collaborate to develop next generation obesity treatments

* ‍Boehringer Ingelheim says Gubra may receive up to EUR 250 million in milestones plus staggered up to double-digit royalties on worldwide net sales​ Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below